COLLEGIUM PHARMACEUTICAL, INC Logo

COLLEGIUM PHARMACEUTICAL, INC

Develops and commercializes abuse-deterrent medications for responsible chronic pain management.

COLL | US

Overview

Corporate Details

ISIN(s):
US19459J1043
LEI:
Country:
United States of America
Address:
100 TECHNOLOGY CENTER DRIVE, 2072 STOUGHTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Collegium Pharmaceutical, Inc. is a specialty biopharmaceutical company dedicated to developing and commercializing medications for people with serious medical conditions. The company's primary focus is on pain management, offering a portfolio of differentiated products designed to treat chronic pain responsibly. A key aspect of its scientific approach is the development of abuse-deterrent formulations. Collegium is engaged in the full lifecycle of its products, from development to commercialization and distribution in the United States, supporting both patients and healthcare providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all COLLEGIUM PHARMACEUTICAL, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COLLEGIUM PHARMACEUTICAL, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for COLLEGIUM PHARMACEUTICAL, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NIPPON CHEMIPHAR CO., LTD. Logo
Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.
Japan 4539
Nippon Shinyaku Co.,Ltd. Logo
Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.
Japan 4516
Nkarta, Inc. Logo
Developing off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America NKTX
NKMAX Co., Ltd. Logo
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea 182400
NLS Pharmaceutics Ltd. Logo
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America NLSP
NovaBay Pharmaceuticals, Inc. Logo
Develops clinically-proven anti-infective therapies for eyecare, skincare, and wound care.
United States of America NBY
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland NOVN
NOVAVAX INC Logo
Develops and commercializes nanoparticle vaccines for serious infectious diseases.
United States of America NVAX
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea 229500

Talk to a Data Expert

Have a question? We'll get back to you promptly.